Recorded Chinese product: 苯丙酸诺龙注射液苯丙酸诺龙注射液
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 浙江仙琚制药股份有限公司Chinese legal name: 浙江仙琚制药股份有限公司
主要成分Active Ingredients
- 苯丙酸诺龙Benbing Suannuo Long
药物知识说明
苯丙酸诺龙是一种在国家药监局注册认定的药品。标注生产企业为浙江仙琚制药股份有限公司。
该药品暂无关联的活性成分信息。
该药品标注的生产企业为：浙江仙琚制药股份有限公司Chinese legal name: 浙江仙琚制药股份有限公司、浙江仙琚制药股份有限公司Chinese legal name: 浙江仙琚制药股份有限公司、浙江仙琚制药股份有限公司Chinese legal name: 浙江仙琚制药股份有限公司。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 苯丙酸诺龙注射液) is a medicine registered with the national drug regulatory authority. It is manufactured by Chinese legal name: 浙江仙琚制药股份有限公司.
No active ingredient relationships are currently recorded for this product in MedicineGraph.
Manufacturers recorded for this product: 浙江仙琚制药股份有限公司Chinese legal name: 浙江仙琚制药股份有限公司, 浙江仙琚制药股份有限公司Chinese legal name: 浙江仙琚制药股份有限公司, 浙江仙琚制药股份有限公司Chinese legal name: 浙江仙琚制药股份有限公司.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 苯丙酸诺龙注射液Recorded Chinese product: 苯丙酸诺龙注射液
- 剂型Dosage form: 注射剂Injection
- 规格Specification: 25mg*1ml*10支25mg*1 mL × 10 units
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
生产企业Manufacturer
- 浙江仙琚制药股份有限公司Chinese legal name: 浙江仙琚制药股份有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H33020712
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H33020712
Manufacturer
Chinese legal name: 浙江仙琚制药股份有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
Protect from light and keep tightly closed.
Specification
25mg*1 mL × 10 units
中文说明书原文Original Chinese source label
批准文号
国药准字H33020712
生产企业
浙江仙琚制药股份有限公司(国产)
适应症
①女性晚期乳腺癌姑息性治疗。 ②伴有蛋白分解的消耗性疾病的治疗。
用法用量
深部肌内注射：成人常用量①女性转移性乳腺癌姑息性治疗：每周25～100mg，肌内注射。一般须持续至12周，如有必要，治疗结束4周后，可进行第二个疗程。②蛋白大量分解的严重消耗性疾病，如严重烧伤、慢性腹泻、大手术后等。每周25～50mg，肌内注射，同时须摄入充足的热量和蛋白质。
不良反应
1.本品有轻微男性化作用，妇女使用后，可能会长胡须，粉刺增多，多毛症，声音变粗，阴蒂肥大、闭经或月经紊乱等反应。
2.男性：长期使用可能会有痤疮、精子减少、精液减少。
3.肝脏：GOP、GTP上升、黄疸。
4.消化系统：恶心、呕吐、消化不良、腹泻。
5.电解质：水钠潴留。
6.皮肤：皮疹、颜面潮红。
禁忌
高血压、孕妇及前列腺癌患者禁用。
注意事项
心脏、肝、肾患者、癌骨转移患者、糖尿病、前列腺肥大患者慎用。
贮藏
遮光，密闭保存。
规格
25mg*1ml*10支
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.